FDA seeking 'aggressive' adoption of AI . The FDA announced an "aggressive timeline" to deploy artificial intelligence ...

The Food and Drug Administration is going all in on artificial intelligence. | The Food and Drug Administration is going all ...

The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline ...

The Food and Drug Administration (FDA) plans to launch generative AI across all of its centers by June 30. The announcement follows the appointment of the agency’s first chief AI officer, Jeremy Walsh ...

Supposedly, the AI tool will speed up the FDA's drug review process by reducing the time its scientists have to spend doing tedious, repetitive tasks — though, given AI's track record of ...

OpenAI has met with the FDA to discuss using AI to speed up drug evaluations, part of the agency’s broader push to adopt AI ...

Major funding continues to pour into the AI healthcare sector, highlighted by Persivia's recent $107 million raise to scale ...

Read about the move to scale use of AI across all FDA centers by the end of June and learn more about future plans to expand ...

The U.S. Food and Drug Administration said on Thursday all its centers will deploy artificial intelligence internally ...

Experts have cautioned against adopting the technology too quickly for clinical purposes. The first meeting of FDA’s Digital Health Advisory Committee in November cited many of generative AI’s ...